CN103153312B - 用于预防性治疗和治疗性治疗疱疹感染的吡罗昔康 - Google Patents

用于预防性治疗和治疗性治疗疱疹感染的吡罗昔康 Download PDF

Info

Publication number
CN103153312B
CN103153312B CN201180021384.XA CN201180021384A CN103153312B CN 103153312 B CN103153312 B CN 103153312B CN 201180021384 A CN201180021384 A CN 201180021384A CN 103153312 B CN103153312 B CN 103153312B
Authority
CN
China
Prior art keywords
piroxicam
reagent
herpes
purposes
prophylactic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201180021384.XA
Other languages
English (en)
Chinese (zh)
Other versions
CN103153312A (zh
Inventor
扬·斯洛曼尼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Slomianny Jan
Original Assignee
Hans Otto Meyer Zu Spelbrink
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hans Otto Meyer Zu Spelbrink filed Critical Hans Otto Meyer Zu Spelbrink
Publication of CN103153312A publication Critical patent/CN103153312A/zh
Application granted granted Critical
Publication of CN103153312B publication Critical patent/CN103153312B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201180021384.XA 2010-04-08 2011-04-06 用于预防性治疗和治疗性治疗疱疹感染的吡罗昔康 Expired - Fee Related CN103153312B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102010014290.5 2010-04-08
DE102010014290A DE102010014290A1 (de) 2010-04-08 2010-04-08 Mittel zur prophylaktischen und therapeutischen Behandlung von Herpes-Infektionen
PCT/EP2011/001704 WO2011124366A1 (de) 2010-04-08 2011-04-06 Piroxicam zur prophylaktischen und therapeutischen behandlung von herpes - infektionen

Publications (2)

Publication Number Publication Date
CN103153312A CN103153312A (zh) 2013-06-12
CN103153312B true CN103153312B (zh) 2015-07-22

Family

ID=43970974

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201180021384.XA Expired - Fee Related CN103153312B (zh) 2010-04-08 2011-04-06 用于预防性治疗和治疗性治疗疱疹感染的吡罗昔康

Country Status (11)

Country Link
US (2) US20130190301A1 (https=)
EP (1) EP2374461B1 (https=)
JP (1) JP6158077B6 (https=)
CN (1) CN103153312B (https=)
CA (1) CA2795334C (https=)
DE (1) DE102010014290A1 (https=)
DK (1) DK2374461T3 (https=)
ES (1) ES2612584T3 (https=)
PL (1) PL2374461T3 (https=)
RU (1) RU2555765C2 (https=)
WO (1) WO2011124366A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010014290A1 (de) * 2010-04-08 2011-10-13 Hans Otto Meyer zu Spelbrink Mittel zur prophylaktischen und therapeutischen Behandlung von Herpes-Infektionen
DE102013003756A1 (de) 2013-03-06 2014-09-11 DeaValorum UG (haftungsbeschränkt) Piroxicam zur prophylaktischen und therapeutischen Behandlung von CMV-Infektionen
DE102013014787A1 (de) 2013-09-09 2015-03-12 Dauphine UG (haftungsbeschränkt) Mittel zur prophylaktischen und therapeutischen Behandlung von EHV-Infektionen

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3437232A1 (de) * 1984-10-10 1986-04-17 Mack Chem Pharm Stabilisierte injektionsloesungen von piroxicam
IT1216686B (it) * 1988-04-01 1990-03-08 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam e procedimento per laloro preparazione.
IT1230922B (it) * 1989-06-23 1991-11-08 Giuseppe De Benedittis Composizione per il trattamento della nevralgia erpetica acuta e della nevralgia post erpetica
DE59003020D1 (de) * 1990-04-26 1993-11-11 Sagitta Arzneimittel Gmbh Piroxicam enthaltende pharmazeutische Zusammensetzung zur topischen Anwendung.
JP3031990B2 (ja) * 1990-10-19 2000-04-10 同仁医薬化工株式会社 消炎鎮痛クリーム剤組成物
RU2182016C2 (ru) * 1997-03-20 2002-05-10 Панацея Биотек Лтд. Спазмолитическая композиция, способ получения спазмолитической композиции
DE10300222A1 (de) * 2003-01-03 2004-07-15 MedInnova Gesellschaft für medizinische Innovationen aus akademischer Forschung mbH Verwendung von Wirksubstanzen zur Prophylaxe und/oder Therapie von Viruserkrankungen
US7132452B2 (en) 2003-03-10 2006-11-07 Fang-Yu Lee Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection
DE102010014290A1 (de) * 2010-04-08 2011-10-13 Hans Otto Meyer zu Spelbrink Mittel zur prophylaktischen und therapeutischen Behandlung von Herpes-Infektionen

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Therapeutic effects of feldene piroxicam on herpes zoster;Yamamoto M,et al.;《Acta Dermatologica (kyoto)》;19841231;第79卷(第4期);第315-320页 *

Also Published As

Publication number Publication date
US20140148447A1 (en) 2014-05-29
WO2011124366A1 (de) 2011-10-13
JP6158077B2 (ja) 2017-07-05
RU2555765C2 (ru) 2015-07-10
EP2374461A1 (de) 2011-10-12
DK2374461T3 (en) 2017-02-06
CN103153312A (zh) 2013-06-12
JP2013523789A (ja) 2013-06-17
PL2374461T3 (pl) 2017-08-31
US20130190301A1 (en) 2013-07-25
CA2795334A1 (en) 2011-10-13
RU2012147474A (ru) 2014-05-20
ES2612584T3 (es) 2017-05-17
DE102010014290A1 (de) 2011-10-13
CA2795334C (en) 2015-06-09
JP6158077B6 (ja) 2018-08-29
EP2374461B1 (de) 2016-10-26

Similar Documents

Publication Publication Date Title
US20090191288A1 (en) Composition to Treat Herpes, Pseudomonas, Staph, Hepatitis and Other Infectious Diseases
US9662360B2 (en) Treatment of herpes, pseudomonas, staph, and hepatitis
JP2004508402A (ja) ヘルペスウイルスの症状再発を遅延させる方法
CA2533591C (en) Method for treatment of sores and lesions of the skin
EA037085B1 (ru) Композиция для устранения заложенности носа, обладающая противовирусным действием
CN103153312B (zh) 用于预防性治疗和治疗性治疗疱疹感染的吡罗昔康
JP2006515361A (ja) ヘルペスウイルス感染の症候を治療又は予防する方法
ES2678122T3 (es) Comprimidos bucales mucoadherentes para el tratamiento del herpes orofacial
Harmenberg et al. ME-609: a treatment for recurrent herpes simplex virus infections
US11951082B2 (en) Composition of chlorhexidine
CN115867288A (zh) 用于治疗呼吸系统病症的组合物
WO2014126508A1 (ru) Фармацевтическая композиция для лечения местных проявлений инфекций, вызванных вирусом простого герпеса и для профилактики гриппа и острых респираторных вирусных инфекций
US20110136837A1 (en) Mucoadhesive buccal tablets for the treatment of orofacial herpes
KR20190040185A (ko) 바이러스 감염의 치료에서 활성제로서의 키보르놀(xibornol)의 용도
CN110538183B (zh) 一种预防和治疗小儿湿疹的组合物及其制备方法
TR201908166T4 (tr) Mukozal lezyonların tedavisi için formülasyonlar.
CN117462633A (zh) 荆银固表方在治疗流感以及流感继发细菌感染疾病中的应用
Amir Primary Herpes Simplex Gingivostomatitis and Recurrent Orolabial Infection
JPH08268901A (ja) ヘルペスウイルスに起因するウイルス感染症再発予防剤
HK40028689A (en) Treatment of herpes simplex symptoms on skin and mucous membrane of mammals
EP2335690A1 (en) Mucoadhesive buccal tablets for the treatment of orofacial herpes
CN105451729A (zh) 抗病毒化合物和组合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20180418

Address after: German Chaanning Bray Hitt

Patentee after: Slomianny Jan

Address before: Hannover

Co-patentee before: Slomianny Jan

Patentee before: HANS OTTO MEYER ZU SPELBRINK

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150722